{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:26:57Z","timestamp":1791181617331,"version":"4.1.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T00:00:00Z","timestamp":1231891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00401-008-0478-8","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T08:22:21Z","timestamp":1231834941000},"page":"227-246","source":"Crossref","is-referenced-by-count":60,"title":["LRRK2 and neurodegeneration"],"prefix":"10.1007","volume":"117","author":[{"given":"Gabriel","family":"Santpere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,14]]},"reference":[{"key":"478_CR1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2990.2007.00888.x","volume":"34","author":"J Alegre-Abarrategui","year":"2008","unstructured":"Alegre-Abarrategui J, Ansorge O, Esiri M, Wade-Martins R (2008) LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson\u2019s disease. Neuropathol Appl Neurobiol 34:272\u2013283","journal-title":"Neuropathol Appl Neurobiol"},{"key":"478_CR2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1742-4658.2008.06301.x","volume":"275","author":"AC Belin","year":"2008","unstructured":"Belin AC, Westerlund M (2008) Parkinson\u2019s disease: a genetic perspective. FEBS J 275:1377\u20131383","journal-title":"FEBS J"},{"key":"478_CR3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/mds.22041","volume":"23","author":"HT Benamer","year":"2008","unstructured":"Benamer HT, de Silva R, Siddiqui KA, Grosset DG (2008) Parkinson\u2019s disease in Arabs: a systematic review. Mov Disord 23:1205\u20131210","journal-title":"Mov Disord"},{"key":"478_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21019","volume":"60","author":"S Biskup","year":"2006","unstructured":"Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu SW, Savitt JM, Waldvogel HJ, Faull RL, Emson PC, Torp R, Ottersen OP, Dawson TM, Dawson VL (2006) Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol 60:557\u2013569","journal-title":"Ann Neurol"},{"key":"478_CR5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2202-8-102","volume":"8","author":"S Biskup","year":"2007","unstructured":"Biskup S, Moore DJ, Rea A, Lorenz-Deperieux B, Coombes CE, Dawson VL, Dawson TM, West AB (2007) Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMV Neurosci 8:102","journal-title":"BMV Neurosci"},{"key":"478_CR6","unstructured":"Biskup S, West AB (2008) Zeroing in on LRRK2-linked pathogeneic mechanisms in Parkinson\u2019s disease. Biochem Biophys Acta. Oct 10 (Epub ahead of print) PMID 18973807"},{"key":"478_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tcb.2005.11.001","volume":"16","author":"DS Carney","year":"2006","unstructured":"Carney DS, Davies BA, Horazdovsky BF (2006) Vps9 domain-containing proteins: activators of Rab5 GTPases from yeast to neurons. Trends Cell Biol 16:27\u201335","journal-title":"Trends Cell Biol"},{"key":"478_CR8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/01.WNL.0000280574.17166.26","volume":"70","author":"AS Chen-Plotkin","year":"2008","unstructured":"Chen-Plotkin AS, Yuan W, Anderson C, Wood EM, Hurtig HI, Clark CM, Miller BL, Lee VM, Trojanowski JQ, Grossman M, Van Deerlin VM (2008) Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology 70:521\u2013527","journal-title":"Neurology"},{"key":"478_CR9","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/01.wnl.0000244345.49809.36","volume":"67","author":"LN Clark","year":"2006","unstructured":"Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote L, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K (2006) Frequency of LRRK2 mutations in early- and late-onset Parkinson\u2019s disease. Neurology 67:1786\u20131791","journal-title":"Neurology"},{"key":"478_CR10","doi-asserted-by":"crossref","unstructured":"Covy JP, Giasson BI (2008) Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. Biochem Biophys Res Commun [Epub ahead of print]","DOI":"10.1016\/j.bbrc.2008.11.048"},{"key":"478_CR11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.21029","volume":"60","author":"JP Covy","year":"2006","unstructured":"Covy JP, Van Deerlin VM, Giasson BI (2006) Lack of evidence for LRRK2 in \u03b1-synuclein pathological inclusions. Ann Neurol 60:618\u2013619","journal-title":"Ann Neurol"},{"key":"478_CR12","doi-asserted-by":"crossref","unstructured":"Covy JP, Yuan W, Waxman EA, Hurtig HI, Van Deerlin VM, Giasson BI (2008) Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations. Mov Disord [Epub ahead of print]","DOI":"10.1002\/mds.22096"},{"key":"478_CR13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-006-0178-1","volume":"113","author":"JC D\u00e4chsel","year":"2007","unstructured":"D\u00e4chsel JC, Ross OA, Mata IF, Kachergus J, Toft M, Cannon A, Baker M, Adamson J, Hutton M, Dickson DW, Farrer MJ (2007) Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathol 113:601\u2013606","journal-title":"Acta Neuropathol"},{"key":"478_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.parkreldis.2007.01.008","volume":"13","author":"JC D\u00e4chsel","year":"2007","unstructured":"D\u00e4chsel JC, Taylor JP, Mok SS, Ross OA, Hinkle KM, Bailey RM, Hines JH, Szutu J, Madden B, Petrucelli L, Farrer MJ (2007) Identification of potential protein interactors of Lrrk2. Parkinsonism Relat Disord 13:382\u2013385","journal-title":"Parkinsonism Relat Disord"},{"key":"478_CR15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ana.20510","volume":"57","author":"H Deng","year":"2005","unstructured":"Deng H, Le W, Guo Y, Hunter CB, Xie W, Jankovic J (2005) Genetic and clinical identification of Parkinson\u2019s disease patients with LRRK2 G2019S mutation. Ann Neurol 57:933\u2013934","journal-title":"Ann Neurol"},{"key":"478_CR16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1073\/pnas.0709098105","volume":"105","author":"J Deng","year":"2008","unstructured":"Deng J, Lewis PA, Greggio E, Sluch E, Beilina A, Cookson MR (2008) Structure of the ROC domain from the Parkinson\u2019s disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci 105:1499\u20131504","journal-title":"Proc Natl Acad Sci"},{"key":"478_CR17","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1111\/j.1742-4658.2008.06707.x","volume":"275","author":"MJ Devine","year":"2008","unstructured":"Devine MJ, Lewis PA (2008) Emerging pathways in genetic Parkinson\u2019s disease: tangles, Lewy bodies and LRRK2. FEBS J 275:5748\u20135757","journal-title":"FEBS J"},{"key":"478_CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","volume":"365","author":"A Di Fonzo","year":"2005","unstructured":"Di Fonzo A, Roh\u00e9 CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V, Italian Parkinson Genetics Network (2005) A frequent LRRK2 mutation gene mutation associated with autosomal dominant Parkinson\u2019s disease. Lancet 365:412\u2013415","journal-title":"Lancet"},{"key":"478_CR19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S1474-4422(08)70118-2","volume":"7","author":"A Elbaz","year":"2008","unstructured":"Elbaz A (2008) LRRK2: bridging the gap between sporadic and hereditary Parkinson\u2019s disease. Lancet Neurol 7:562\u2013564","journal-title":"Lancet Neurol"},{"key":"478_CR20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1212\/01.WNL.0000169023.51764.b0","volume":"65","author":"M Farrer","year":"2005","unstructured":"Farrer M, Stone J, Mata IF, Lincoln S, Kachergus J, Hulihan M, Strain KJ, Maraganore DM (2005) LRRK2 mutations in Parkinson disease. Neurology 65:738\u2013740","journal-title":"Neurology"},{"key":"478_CR21","first-page":"450","volume":"5","author":"I Ferrer","year":"2003","unstructured":"Ferrer I, Hernandez I, Puig B, Rey MJ, Ezquerra M, Tolosa E, Boada M (2003) Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in p30l tauopathy. J Alzheimers Dis 5:450\u2013454","journal-title":"J Alzheimers Dis"},{"key":"478_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS (1996) Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol 55:259\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"key":"478_CR23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2\u2013q13.1. Ann Neurol 51:296\u2013301","journal-title":"Ann Neurol"},{"key":"478_CR24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.20484","volume":"57","author":"M Funayama","year":"2005","unstructured":"Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57:918\u2013921","journal-title":"Ann Neurol"},{"key":"478_CR25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archneur.63.3.377","volume":"63","author":"C Gaig","year":"2006","unstructured":"Gaig C, Ezquerra M, Marti E, Mu\u00f1oz E, Vallderiola F, Tolosa E (2006) LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 63:377\u2013382","journal-title":"Arch Neurol"},{"key":"478_CR26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.2006.107904","volume":"78","author":"C Gaig","year":"2007","unstructured":"Gaig C, Mart\u00ed MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E (2007) G2019S LRRK2 mutation causing Parkinson\u2019s disease without Lewy bodies. J Neurol Neurosurg Psychiatr 78:626\u2013628","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"478_CR27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.20808","volume":"59","author":"D Galter","year":"2006","unstructured":"Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L (2006) LRRK2 expression linked to dopamine-innervated areas. Ann Neurol 59:714\u2013719","journal-title":"Ann Neurol"},{"key":"478_CR28","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jnr.21622","volume":"86","author":"PN Gandhi","year":"2008","unstructured":"Gandhi PN, Wang X, Zhu X, Chen SG, Wilson-DElfosse AL (2008) The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res 86:1711\u20131720","journal-title":"J Neurosci Res"},{"key":"478_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000109764","volume":"16","author":"BI Giasson","year":"2008","unstructured":"Giasson BI, Van Deerlin VM (2008) Mutations in LRRK2 as a cause of Parkinson\u2019s disease. Neurosignals 16:99\u2013105","journal-title":"Neurosignals"},{"key":"478_CR30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"BI Giasson","year":"2006","unstructured":"Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ, Van Deerlin VM (2006) Biochemical and pathological characterization of Lrrk2. Ann Neurol 59:315\u2013322","journal-title":"Ann Neurol"},{"key":"478_CR31","first-page":"415","volume":"365","author":"WP Gilks","year":"2005","unstructured":"Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW (2005) A common LRRK2 mutation in idiopathic Parkinson\u2019s disease. Lancet 365:415\u2013416","journal-title":"Lancet"},{"key":"478_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/mds.21281","volume":"22","author":"MT Giordana","year":"2007","unstructured":"Giordana MT, D\u2019Agostino C, Albani G, Mauro A, Di Fonzio A, Antonini A, Bonifaci V (2007) Neuropathology of Parkinson\u2019s disease associated with LRRK2 Ile1371Val mutation. Mov Disord 22:275\u2013278","journal-title":"Mov Disord"},{"key":"478_CR33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","volume":"15","author":"CJ Gloeckner","year":"2006","unstructured":"Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O\u2019Neill E, Meitinger T, Kolch W, Prokisch H, Ueffing M (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 15:223\u2013232","journal-title":"Hum Mol Genet"},{"key":"478_CR34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/01.wnl.0000254483.19854.ef","volume":"68","author":"S Goldwurm","year":"2007","unstructured":"Goldwurm S, Zini M, Mariani L, Tesei S, Miceli R, Sironi F, Clementi M, Bonifati V, Pezzoli G (2007) Evaluation of LRRK2 G2019S penetrance: relevance for genetic counselling in Parkinson disease. Neurology 68:1141\u20131143","journal-title":"Neurology"},{"key":"478_CR35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","volume":"23","author":"E Greggio","year":"2006","unstructured":"Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR (2006) Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin. Neurobiol Dis 23:329\u2013341","journal-title":"Neurobiol Dis"},{"key":"478_CR36","doi-asserted-by":"crossref","first-page":"16906","DOI":"10.1074\/jbc.M708718200","volume":"283","author":"E Greggio","year":"2008","unstructured":"Greggio E, Zambrano I, Kaganovich A, Beilina A, Taymans JM, Daniels V, Lewis P, Jain S, Ding J, Syed A, Thomas KJ, Baekelandt V, Cookson MR (2008) The Parkinson\u2019s disease associated Leucine rich repeat kinase 2 (LRRK2) is a dimer that undergoes intra-molecular autophosphorylation. J Biol Chem 283:16906\u201316914","journal-title":"J Biol Chem"},{"key":"478_CR37","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.yexcr.2007.07.007","volume":"313","author":"L Guo","year":"2007","unstructured":"Guo L, Gandhi PN, Wang W, Petersen RB, Wilson-Delfosse AL, Chen SG (2007) The Parkinson\u2019s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp Cell Res 313:3658\u20133670","journal-title":"Exp Cell Res"},{"key":"478_CR38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10048-007-0114-0","volume":"9","author":"K H\u00e4big","year":"2008","unstructured":"H\u00e4big K, Walter M, Poths S, Bonin M (2008) RNA interference of LRRK2-microarray expression analysis of a Parkinson\u2019s disease key player. Neurogenetics 9:83\u201394","journal-title":"Neurogenetics"},{"key":"478_CR39","doi-asserted-by":"crossref","unstructured":"Han BS, Iacovitti L, Katano T, Hattori N, Seol W, Kim KS (2008) Expression of LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra. Neurosci Lett (Epub ahead of print)","DOI":"10.1016\/j.neulet.2008.06.086"},{"key":"478_CR40","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/hmg\/ddm013","volume":"16","author":"T Hatano","year":"2007","unstructured":"Hatano T, Kubo S, Imai S, Maeda M, Ishikawa K, Mizuno Y, Hattori N (2007) Leucine-rich repeat kinase 2 associates with lipid rafts. Hum Mol Genet 16:678\u2013690","journal-title":"Hum Mol Genet"},{"key":"478_CR41","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/01.wnl.0000304044.22253.03","volume":"70","author":"K Haugarvoll","year":"2008","unstructured":"Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tlosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theurns J, Pals P, Cras P, DeDeyn PP, Engelborghs S, Pickut B, Uiti RJ, Foroud T, Nichols WC, Hagenah J, Klein C, Samii A, Zabetian CP, Bonifacti V, Van Broeckhoven C, Farrer MJ, Wszolek ZK (2008) LRRK2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70:1456\u20131460","journal-title":"Neurology"},{"key":"478_CR42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11910-006-0020-0","volume":"6","author":"K Haugarvoll","year":"2006","unstructured":"Haugarvoll K, Wszolek ZK (2006) PARK8 LRRK2 parkinsonism. Curr Neurol Neurosci Rep 6:287\u2013294","journal-title":"Curr Neurol Neurosci Rep"},{"key":"478_CR43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW, International LRRK2 Consortium (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case\u2013control study. Lancet Neurol 7:583\u2013590","journal-title":"Lancet Neurol"},{"key":"478_CR44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2007.04.034","volume":"1155","author":"S Higashi","year":"2007","unstructured":"Higashi S, Biskup S, West AB, Trinkaus D, Dawson VL, Faull RL, Waldvogel HJ, Arai H, Dawson TM, Moore DJ, Emson PC (2007) Localization of Parkinson\u2019s disease-associated LRRK2 in normal and pathological human brain. Brain Res 1155:208\u2013219","journal-title":"Brain Res"},{"key":"478_CR45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2006.04246.x","volume":"100","author":"S Higashi","year":"2007","unstructured":"Higashi S, Moore DJ, Colebrooke RE, Biskup S, Dawson VL, Arai H, Dawson TM, Emson PC (2007) Expression and localization of Parkinson\u2019s disease-associated leucine-rich repeat kinase 2 in the mouse brain. J Neurochem 100:368\u2013381","journal-title":"J Neurochem"},{"key":"478_CR46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-008-0446-3","volume":"116","author":"Y Huang","year":"2008","unstructured":"Huang Y, Song YJ, Murphy K, Holton JL, Lashley T, Revesz T, Gai WP, Halliday GM (2008) LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions. Acta Neuropathol 116:639\u2013646","journal-title":"Acta Neuropathol"},{"key":"478_CR47","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1523\/JNEUROSCI.1870-08.2008","volume":"28","author":"A Hurtado-Lorenzo","year":"2008","unstructured":"Hurtado-Lorenzo A, Anand VS (2008) Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson\u2019s disease treatment. J Neurosci 28:6757\u20136759","journal-title":"J Neurosci"},{"key":"478_CR48","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/hmg\/ddm080","volume":"16","author":"C Iaccarino","year":"2007","unstructured":"Iaccarino C, Crosio C, Vitale C, Sanna G, Carri MT, Barone P (2007) Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum Mol Genet 16:1319\u20131326","journal-title":"Hum Mol Genet"},{"key":"478_CR49","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/archneur.63.9.1250","volume":"63","author":"L Ishihara","year":"2006","unstructured":"Ishihara L, EWarren L, Gibson R, Amouri R, Lesage S, Durr A, Tazir M, Wszolek ZK, Uiti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, Foroud TM, Farrer MJ, Brice A, Middleton L, Hentati F (2006) Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 63:1250\u20131254","journal-title":"Arch Neurol"},{"key":"478_CR50","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/bi061960m","volume":"46","author":"G Ito","year":"2007","unstructured":"Ito G, Okai T, Fujino G, Takeda K, Ichijo H, Katada T, Iwatsubo T (2007) GTPbinding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson\u2019s disease. Biochemistry 46:1380\u20131388","journal-title":"Biochemistry"},{"key":"478_CR51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20070209","volume":"405","author":"M Jaleel","year":"2007","unstructured":"Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, Knebel A, Alessi DR (2007) LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson\u2019s disease mutants affect kinase activity. Biochem J 405:307\u2013317","journal-title":"Biochem J"},{"key":"478_CR52","first-page":"169","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"K Jellinger","year":"2003","unstructured":"Jellinger K, Mizuno Y (2003) Parkinson\u2019s disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropathol Press, Basel, pp 169\u2013187"},{"key":"478_CR53","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/429256","volume":"76","author":"J Kachergus","year":"2005","unstructured":"Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aaasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganone DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M (2005) Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European population. Am J Hum Genet 76:672\u2013680","journal-title":"Am J Hum Genet"},{"key":"478_CR54","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/brain\/awh667","volume":"128","author":"NL Khan","year":"2005","unstructured":"Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, Healy DG, Gilks WP, Sweeney MG, Ganguly M, Gibbons V, Gandhi S, Vaughan J, Eunson LH, Katzenschlager R, Gayton J, Lennox G, Revesz T, Nicholl D, Bhatia KP, Quinn N, Brooks D, Lees AJ, Davis MB, Piccini P, Singleton AB, Wood NW (2005) Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson\u2019s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 128:2786\u20132796","journal-title":"Brain"},{"key":"478_CR55","doi-asserted-by":"crossref","unstructured":"Larsen K, Madsen LB (2007) Sequence conservation between porcine and human LRRK2. Mol Biol Rep (Epub ahead of print)","DOI":"10.1007\/s11033-007-9172-5"},{"key":"478_CR56","doi-asserted-by":"crossref","unstructured":"Lee SB, Kim W, Lee S, Chung (2007) Loss of LRRK2\/PARK8 induces degeneration of dopaminergic neurons in Drosophila. Biochem Biophys Res Commun 358:534\u2013539","DOI":"10.1016\/j.bbrc.2007.04.156"},{"key":"478_CR57","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","volume":"354","author":"S Lesage","year":"2006","unstructured":"Lesage S, Durr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A (2006) LRRK2 G2019S as a cause of Parkinson\u2019s disease in North African Arabs. N Engl J Med 354:422\u2013423","journal-title":"N Engl J Med"},{"key":"478_CR58","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/432422","volume":"77","author":"S Lesage","year":"2005","unstructured":"Lesage S, Leutenegger AL, Ibanez P, Janin S, Lohmann E, Durr A, Brice A (2005) LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 77:330\u2013332","journal-title":"Am J Hum Genet"},{"key":"478_CR59","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2007.04.006","volume":"357","author":"PA Lewis","year":"2007","unstructured":"Lewis PA, Greggio E, Beilina A, Jain S, Baker A, Cookson MR (2007) The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun 357:668\u2013671","journal-title":"Biochem Biophys Res Commun"},{"key":"478_CR60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1471-4159.2007.04743.x","volume":"103","author":"X Li","year":"2007","unstructured":"Li X, Tan YC, Poulose S, Olanow CW, Huang XY, Yue Z (2007) Leucine-rich repeat kinase 2 (LRRK2)\/PARK8 possesses GTPase activity that is altered in familial Parkinson\u2019s disease R1441C\/G mutants. J Neurochem 103:238\u2013247","journal-title":"J Neurochem"},{"key":"478_CR61","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1073\/pnas.0708452105","volume":"105","author":"Z Liu","year":"2008","unstructured":"Liu Z, Wang X, Yu Y, Li X, Wang T, Jiang H, Ren Q, Jiao Y, Sawa A, Moran T, Ross CA, Montell C, Smith WW (2008) A Drosophila model for LRRK2-linked parkinsonism. Proc Natl Acad Sci USA 105:2693\u20132698","journal-title":"Proc Natl Acad Sci USA"},{"key":"478_CR62","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/jnr.21656","volume":"86","author":"YW Lu","year":"2008","unstructured":"Lu YW, Tan EK (2008) Molecular biology changes associated with LRRK2 mutations in Parkinson\u2019s disease. J Neurosci Res 86:1895\u20131901","journal-title":"J Neurosci Res"},{"key":"478_CR63","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddm151","volume":"16","author":"B Luzon-Toro","year":"2007","unstructured":"Luzon-Toro B, Rubio la Torre de E, Delgado A, Perez-Tur J, Hilfiker S (2007) Mechanistic insight into the dominant mode of the Parkinson\u2019s disease-associated G2019S LRRK2 mutation. Hum Mol Genet 16:2031\u20132039","journal-title":"Hum Mol Genet"},{"key":"478_CR64","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","volume":"52","author":"D MacLeod","year":"2006","unstructured":"MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52:587\u2013593","journal-title":"Neuron"},{"key":"478_CR65","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/molbev\/msl114","volume":"23","author":"I Marin","year":"2006","unstructured":"Marin I (2006) The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol Biol Evol 23:2423\u20132433","journal-title":"Mol Biol Evol"},{"key":"478_CR66","doi-asserted-by":"crossref","unstructured":"Mar\u00edn I (2008) Ancient origin of the Parkinson disease gene LRRK2. J Mol Evol (Epub ahead of print)","DOI":"10.1007\/s00239-008-9122-4"},{"key":"478_CR67","doi-asserted-by":"crossref","unstructured":"Marin I, van Egmond WN, van Haastert PJ (2008) The Rocco protein family: a functional perspective. FASEB J (Epub ahead of print)","DOI":"10.1096\/fj.08-111310"},{"key":"478_CR68","doi-asserted-by":"crossref","unstructured":"Mart\u00ed-Mass\u00f3 JF, Ruiz-Martinez J, Bola\u00f1o MJ, Ruiz I, Gorostidi A, Moreno F, Ferrer I, L\u00f3pez de Munain A (2008) Neuropathology of Parkinson disease with the R1441G mutation in LRRK2 (submitted)","DOI":"10.1002\/mds.22677"},{"key":"478_CR69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10048-005-0005-1","volume":"6","author":"IF Mata","year":"2005","unstructured":"Mata IF, Kachergus JM, Taylor JP, Lincoln S, Aasly J, Lynch T, Hulihan MM, Cobb SA, Wu RM, Lu CS, Lahoz C, Wszolek ZK, Farrer MJ (2005) Lrrk2 pathogenic substitutions in Parkinson\u2019s disease. Neurogenetics 6:171\u2013177","journal-title":"Neurogenetics"},{"key":"478_CR70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tins.2006.03.006","volume":"29","author":"IF Mata","year":"2006","unstructured":"Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA (2006) LRRK2 in Parkinson\u2019s disease: protein domains and functional insights. Trends Neurosci 29:286\u2013293","journal-title":"Trends Neurosci"},{"key":"478_CR71","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.neuroscience.2007.05.027","volume":"147","author":"HL Melrose","year":"2007","unstructured":"Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, Delldonne A, Dickson DW (2007) A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience 147:1047\u20131058","journal-title":"Neuroscience"},{"key":"478_CR72","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neuroscience.2006.01.017","volume":"139","author":"H Melrose","year":"2006","unstructured":"Melrose H, Lincoln S, Tyndall G, Dickson D, Farrer M (2006) Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience 139:791\u2013794","journal-title":"Neuroscience"},{"key":"478_CR73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2005.01.003","volume":"30","author":"E Meylan","year":"2005","unstructured":"Meylan E, Tschopp J (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30:151\u2013159","journal-title":"Trends Biochem Sci"},{"key":"478_CR74","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","volume":"65","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Arai T, Guo JP, Klegeris A, Yu S, McGeer EG, McGeer PL (2006) LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol 65:953\u2013963","journal-title":"J Neuropathol Exp Neurol"},{"key":"478_CR75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00401-007-0230-9","volume":"114","author":"J Miklossy","year":"2007","unstructured":"Miklossy J, Qing H, Guo JP, Yu S, Wszolek ZK, Calne D, McGeer EG, McGeer PL (2007) Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation. Acta Neuropathol 114:243\u2013254","journal-title":"Acta Neuropathol"},{"key":"478_CR76","doi-asserted-by":"crossref","unstructured":"Moore DJ (2008) The biology and pathobiology of LRRK2: implications for Parkinson\u2019s disease. Parkinsonism Relat Disord 14(suppl 2):S92\u2013S98","DOI":"10.1016\/j.parkreldis.2008.04.010"},{"key":"478_CR77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/dnares\/dsl006","volume":"13","author":"N Nakamura","year":"2006","unstructured":"Nakamura N, Shimaoka Y, Tougan T, Onda H, Okuzaki D, Zhao H, Fujimori A, Yabuta N, Nagamori I, Tanigawa A, Sato J, Oda T, Hayashida K, Suzuki R, Yukioka M, Nojima H, Ochi T (2006) Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients. DNA Res 13:169\u2013183","journal-title":"DNA Res"},{"key":"478_CR78","first-page":"410","volume":"365","author":"WC Nichols","year":"2005","unstructured":"Nichols WC, Pankratz N, Hernandez D, Paisa-Ruiz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson\u2019s disease. Lancet 365:410\u2013412","journal-title":"Lancet"},{"key":"478_CR79","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/01.wnl.0000277637.33328.d8","volume":"69","author":"A Orr-Urtreger","year":"2007","unstructured":"Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N (2007) The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology 69:1595\u20131602","journal-title":"Neurology"},{"key":"478_CR80","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","volume":"354","author":"LJ Ozelius","year":"2006","unstructured":"Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB (2006) LRRK2 G2019S as a cause of Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med 354:424\u2013425","journal-title":"N Engl J Med"},{"key":"478_CR81","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Mart\u00ed-Mass\u00f3 JF, Perez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44:595\u2013600","journal-title":"Neuron"},{"key":"478_CR82","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/humu.20668","volume":"29","author":"C Paisan-Ruiz","year":"2008","unstructured":"Paisan-Ruiz C, Nath P, Washecka N, Gibbs JR, Singleton AB (2008) Comprehensive analysis of LRRK2 in publicly available Parkinson\u2019s disease cases and neurologically normal controls. Hum Mutat 29:485\u2013490","journal-title":"Hum Mutat"},{"key":"478_CR83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000113708","volume":"5","author":"G Perry","year":"2008","unstructured":"Perry G, Zhu X, Babar AK, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Chen SG (2008) Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson\u2019s disease, but not tau-containing neurons in tauopathies. Neurodegener Dis 5:222\u2013224","journal-title":"Neurodegener Dis"},{"key":"478_CR84","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","volume":"105","author":"ED Plowey","year":"2008","unstructured":"Plowey ED, Cherra SJ, Liu YJ, Chu CT (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 105:1048\u20131056","journal-title":"J Neurochem"},{"key":"478_CR85","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","volume":"67","author":"A Rajput","year":"2006","unstructured":"Rajput A, Dickson DW, Robinson CA, Ross OA, D\u00e4chael JC, Lincoln SJ, Cobb SA, Rajput ML, Farrer MJ (2006) Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67:1506\u20131508","journal-title":"Neurology"},{"key":"478_CR86","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","volume":"59","author":"OA Ross","year":"2006","unstructured":"Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW (2006) LRRK2 and Lewy body disease. Ann Neurol 59:388\u2013393","journal-title":"Ann Neurol"},{"key":"478_CR87","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.yexcr.2008.02.015","volume":"314","author":"N Shin","year":"2008","unstructured":"Shin N, Jeong H, Kwon J, Heo HY, Kwon JJ, Yun HJ, Kim CH, Han BS, Tong Y, Shen J, Hatano T, Hattori N, Kim KS, Chang S, Seol W (2008) LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res 314:2055\u20132065","journal-title":"Exp Cell Res"},{"key":"478_CR88","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Shults","year":"2006","unstructured":"Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661\u20131668","journal-title":"Proc Natl Acad Sci USA"},{"key":"478_CR89","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1460-9568.2006.04616.x","volume":"23","author":"J Simon-Sanchez","year":"2006","unstructured":"Simon-Sanchez J, Herranz-Perez V, Olucha-Bordonau F, Perez-Tur J (2006) LRRK2 is expressed in areas affected by Parkinson\u2019s disease in the adult mouse brain. Eur J NeuroSci 23:659\u2013666","journal-title":"Eur J NeuroSci"},{"key":"478_CR90","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1212\/01.wnl.0000180517.70572.37","volume":"25","author":"L Skipper","year":"2005","unstructured":"Skipper L, Shen H, Chua E, Bonnnard C, Kolatkar P, Tan LC, Jamora RD, Puvan K, Puong KY, Zhao Y, Pavanni R, Wong MC, Yuen Y, Farrer M, Liu JJ, Tan EK (2005) Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology 25:1319\u20131321","journal-title":"Neurology"},{"key":"478_CR91","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9:1231\u20131233","journal-title":"Nat Neurosci"},{"key":"478_CR92","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","volume":"102","author":"WW Smith","year":"2005","unstructured":"Smith WW, Pei Z, Jiang H, Moore DJ, Liang West AB, Dawson VL, Dawson TM, Ross CA (2005) Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci USA 102:18676\u201318681","journal-title":"Proc Natl Acad Sci USA"},{"key":"478_CR93","doi-asserted-by":"crossref","unstructured":"Stenmark H, Olkkonen VM (2001) The Rab GTPase family. Genome Biol 2:reviews3007.1\u2013reviews3007.7","DOI":"10.1186\/gb-2001-2-5-reviews3007"},{"key":"478_CR94","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/humu.20507","volume":"28","author":"EK Tan","year":"2007","unstructured":"Tan EK, Skipper LM (2007) Pathogenic mutations in Parkinson disease. Hum Mutat 28:641\u2013653","journal-title":"Hum Mutat"},{"key":"478_CR95","doi-asserted-by":"crossref","unstructured":"Tan EK, Tan LC, Lim HQ, Li R, Tang M, Yih Y, Pavanni R, Prakash KM, Fook-Chong S, Zhao Y (2008) LRRK2 R1628P increases risk of Parkinson\u2019s disease: replication evidence. Hum Genet (Epub ahead of print)","DOI":"10.1007\/s00439-008-0544-2"},{"key":"478_CR96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2005.12.004","volume":"12","author":"JP Taylor","year":"2006","unstructured":"Taylor JP, Mata IF, Farrer MJ (2006) LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? Trends Mol Med 12:76\u201382","journal-title":"Trends Mol Med"},{"key":"478_CR97","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1471-4159.2006.03919.x","volume":"98","author":"JM Taymans","year":"2006","unstructured":"Taymans JM, Van den Haute C, Baekelandt V (2006) Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 98:951\u2013961","journal-title":"J Neurochem"},{"key":"478_CR98","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","volume":"291","author":"JC Venter","year":"2001","unstructured":"Venter JC et al (2001) The sequence of human genome. Science 291:1304\u20131351","journal-title":"Science"},{"key":"478_CR99","doi-asserted-by":"crossref","unstructured":"Wang D, Tang B, Zhao G, Pan Q, Xia K, Bodmer R, Zhang Z (2008) Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons. Mol Neurodegener (Epub ahead of print)","DOI":"10.1186\/1750-1326-3-3"},{"key":"478_CR100","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM (2005) Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 102:16842\u201316847","journal-title":"Proc Natl Acad Sci USA"},{"key":"478_CR101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","volume":"16","author":"AB West","year":"2007","unstructured":"West AB, Moore DJ, Choi C, Andrabi SA, Li X, Dikeman D, Biskup S, Zhang Z, Lim KL, Dawson VL, Dawson TM (2007) Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet 16:223\u2013232","journal-title":"Hum Mol Genet"},{"key":"478_CR102","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuroscience.2007.10.062","volume":"152","author":"M Westerlund","year":"2008","unstructured":"Westerlund M, Belin AC, Anvret A, Bickford P, Olson L, Galter D (2008) Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: implications for Parkinson\u2019s disease. Neuroscience 152:429\u2013436","journal-title":"Neuroscience"},{"key":"478_CR103","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000113697","volume":"5","author":"B Wolozin","year":"2008","unstructured":"Wolozin B, Saha S, Guillily M, Ferre A, Riley M (2008) Investigating convergent actions of genes linked to familial Parkinson\u2019s disease. Neurodegener Dis 5:182\u2013185","journal-title":"Neurodegener Dis"},{"key":"478_CR104","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/01.WNL.0000125015.06989.DB","volume":"62","author":"ZK Wszolek","year":"2004","unstructured":"Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, M\u00fcller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW (2004) Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 62:1619\u20131622","journal-title":"Neurology"},{"key":"478_CR105","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/508025","volume":"79","author":"CP Zabetian","year":"2006","unstructured":"Zabetian CP, Hunmter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H (2006) LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 79:752\u2013758","journal-title":"Am J Hum Genet"},{"key":"478_CR106","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/01.WNL.0000160116.65034.12","volume":"64","author":"JJ Zarranz","year":"2005","unstructured":"Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atares B, Puig B, Gomez-Esteban JG, Fernandez-Maiztegui C, Rouco I, Perez-Concha T, Fernandez M, Rodriguez O, Rodriguez-Martinez AB, Martinez de Pancorbo M, Pastor P, Perez-Tur J (2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64:1578\u20131585","journal-title":"Neurology"},{"key":"478_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-1-1","volume":"1","author":"X Zhu","year":"2006","unstructured":"Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG (2006) LRRK2 in Parkinson\u2019s disease and dementia with Lewy bodies. Mol Neurodeg 1:1\u20139","journal-title":"Mol Neurodeg"},{"key":"478_CR108","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.20928","volume":"60","author":"X Zhu","year":"2006","unstructured":"Zhu X, Siedlak SL, Smith MA, Perry G, Chen SG (2006) LRRK2 protein is a component of Lewy bodies. Ann Neurol 60:617\u2013618 author reply 618\u2013619","journal-title":"Ann Neurol"},{"key":"478_CR109","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607","journal-title":"Neuron"},{"key":"478_CR110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/380647","volume":"74","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Muller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T (2004) The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 74:11\u201319","journal-title":"Am J Hum Genet"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-008-0478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-008-0478-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-008-0478-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:28:28Z","timestamp":1709944108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-008-0478-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,14]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1007\/s00401-008-0478-8","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,14]]}}}